176 related articles for article (PubMed ID: 35463214)
21. Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance.
Hetland TE; Nymoen DA; Holth A; Brusegard K; Flørenes VA; Kærn J; Tropé CG; Davidson B
Hum Pathol; 2013 May; 44(5):777-85. PubMed ID: 23114921
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle proteins predict recurrence in stage II and III colon cancer.
Belt EJ; Brosens RP; Delis-van Diemen PM; Bril H; Tijssen M; van Essen DF; Heymans MW; Beliën JA; Stockmann HB; Meijer S; Meijer GA
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S682-92. PubMed ID: 22311118
[TBL] [Abstract][Full Text] [Related]
23. Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions.
Dar AA; Zaika A; Piazuelo MB; Correa P; Koyama T; Belkhiri A; Washington K; Castells A; Pera M; El-Rifai W
Cancer; 2008 Apr; 112(8):1688-98. PubMed ID: 18311783
[TBL] [Abstract][Full Text] [Related]
24. AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.
Kalous O; Conklin D; Desai AJ; Dering J; Goldstein J; Ginther C; Anderson L; Lu M; Kolarova T; Eckardt MA; Langerød A; Børresen-Dale AL; Slamon DJ; Finn RS
Breast Cancer Res Treat; 2013 Oct; 141(3):397-408. PubMed ID: 24091768
[TBL] [Abstract][Full Text] [Related]
25. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.
Efstathiou JA; Mouw KW; Gibb EA; Liu Y; Wu CL; Drumm MR; da Costa JB; du Plessis M; Wang NQ; Davicioni E; Feng FY; Seiler R; Black PC; Shipley WU; Miyamoto DT
Eur Urol; 2019 Jul; 76(1):59-68. PubMed ID: 30712971
[TBL] [Abstract][Full Text] [Related]
26. Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer.
Dotan E; Meropol NJ; Zhu F; Zambito F; Bove B; Cai KQ; Godwin AK; Golemis EA; Astsaturov I; Cohen SJ
Br J Cancer; 2012 Feb; 106(4):748-55. PubMed ID: 22240781
[TBL] [Abstract][Full Text] [Related]
27. Genetic Interactions between the Aurora Kinases Reveal New Requirements for AURKB and AURKC during Oocyte Meiosis.
Nguyen AL; Drutovic D; Vazquez BN; El Yakoubi W; Gentilello AS; Malumbres M; Solc P; Schindler K
Curr Biol; 2018 Nov; 28(21):3458-3468.e5. PubMed ID: 30415701
[TBL] [Abstract][Full Text] [Related]
28. High expression of aurora kinase B predicts poor prognosis in hepatocellular carcinoma after curative surgery and its effects on the tumor microenvironment.
Zhao H; Wang Y; Yang Z; Wei W; Cong Z; Xie Y
Ann Transl Med; 2022 Nov; 10(21):1168. PubMed ID: 36467342
[TBL] [Abstract][Full Text] [Related]
29.
Al-Khafaji ASK; Marcus MW; Davies MPA; Risk JM; Shaw RJ; Field JK; Liloglou T
Oncol Lett; 2017 Jun; 13(6):4463-4468. PubMed ID: 28588715
[TBL] [Abstract][Full Text] [Related]
30. Single nucleotide polymorphisms rs911160 in AURKA and rs2289590 in AURKB mitotic checkpoint genes contribute to gastric cancer susceptibility.
Mesic A; Markocic E; Rogar M; Juvan R; Hudler P; Komel R
Environ Mol Mutagen; 2017 Dec; 58(9):701-711. PubMed ID: 28843004
[TBL] [Abstract][Full Text] [Related]
31. Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.
Goos JA; Coupe VM; Diosdado B; Delis-Van Diemen PM; Karga C; Beliën JA; Carvalho B; van den Tol MP; Verheul HM; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
Br J Cancer; 2013 Oct; 109(9):2445-52. PubMed ID: 24104968
[TBL] [Abstract][Full Text] [Related]
32. RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.
Duan L; Perez RE; Calhoun S; Maki CG
Sci Rep; 2022 Jan; 12(1):1049. PubMed ID: 35058503
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
34. Aurora Kinase A Is a Prognostic Marker in Colorectal Adenocarcinoma.
Koh HM; Jang BG; Hyun CL; Kim YS; Hyun JW; Chang WY; Maeng YH
J Pathol Transl Med; 2017 Jan; 51(1):32-39. PubMed ID: 28013532
[TBL] [Abstract][Full Text] [Related]
35. AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma.
Xiao J; Zhang Y
Evol Bioinform Online; 2021; 17():11769343211057589. PubMed ID: 34866894
[TBL] [Abstract][Full Text] [Related]
36. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data.
Lane G; Risk M; Fan Y; Krishna S; Konety B
BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053
[TBL] [Abstract][Full Text] [Related]
37. Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.
Yen CC; Yeh CN; Cheng CT; Jung SM; Huang SC; Chang TW; Jan YY; Tzeng CH; Chao TC; Chen YY; Yang CY; Ho CL; Fletcher JA
Ann Surg Oncol; 2012 Oct; 19(11):3491-9. PubMed ID: 22588468
[TBL] [Abstract][Full Text] [Related]
38. Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis.
Feng Y; Jiang Y; Wen T; Meng F; Shu X
Pathol Oncol Res; 2020 Apr; 26(2):1063-1072. PubMed ID: 31011911
[TBL] [Abstract][Full Text] [Related]
39. Predictive and prognostic value of aurora kinase A combined with tumor-infiltrating lymphocytes in medullary thyroid carcinoma.
Wang Z; Guo F; Fu G; Zhao Z; Kang N; Hou X; Zheng X
Front Oncol; 2024; 14():1379420. PubMed ID: 38903715
[TBL] [Abstract][Full Text] [Related]
40. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
Borah NA; Reddy MM
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
